BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Daniel­Ribeiro CT. Is there a role for autoimmunity in immune protection against malaria? Mem Inst Oswaldo Cruz 2000 Mar­2000 Apr 30;95(2):199­207.
Danovaro­Holliday MC, LeBaron CW, Allensworth C, Raymond R, Borden TG, Murray AB, Icenogle JP, Reef SE. A large rubella outbreak with spread from
the workplace to the community. JAMA 2000 Dec 6;284(21):2733­9
Darden PM. Assessing immunization rates: the importance of denominators [editorial]. Pediatrics 2000 Jul;106(1 Pt 2):169­70.
Dargan JM, Coplan PM, Kaplan KM, Nikas A. Reemergence of invasive Haemophilus influenzae type b disease in Alaska: Is it because of vaccination with
polyribosylribitol phosphate outer membrane protein complex (PRP­OMPC) or failure to vaccinate with PRP­OMPC? [letter]. J Infect Dis 2000;
181(2):806­809.
D'Argenio, P.; Arigliani, R.; Selvaggi, T. M. ReField evaluation of the clinical effectiveness of vaccines against pertusis, measles, rubella, and mumps [letter].
Vaccine 2000 Jul 1;18(26):2925­6.
Davidkina I, Peltolab H, Leinikkia P, Vallea M. Duration of rubella immunity induced by two­dose measles, mumps and rubella (MMR) vaccination. A 15­
year follow­up in Finland. Vaccine 2000 Jul 15;18(27):3106­12.
Davidson RN. Childhood tuberculosis­­problems ahead. Trans R Soc Trop Med Hyg 2000; 94(1):5­6.
Davies MK, Mayne AJ. Stamps in paediatrics. Immunisation. Arch Dis Child 2000; 82(4):282.
Davis ID. An overview of cancer immunotherapy. Immunol Cell Biol 2000 Jun;78(3):179­95.
Davis RL. Vaccine extraimmunization­­too much of a good thing? [editorial; comment]. JAMA 2000;1339­40.
De Keyser F, Naeyaert JM, Hindryckx P, Elewaut D, Verplancke P, Peene I et al. Immune­mediated pathology following hepatitis B vaccination. Two cases of
polyarteritis nodosa and one case of pityriasis rosea­like drug eruption. Clin Exp Rheumatol 2000; 18(1):81­85.
De Keyser F, Naeyaert JM, Hindryckx P, Elewaut D, Verplancke P, Peene I, Praet M, Veys E. Immunemediated pathology following hepatitis B vaccination.
Two cases of polyarteritis nodosa and one case of pityriasis rosea­like drug eruption. Clin Exp Rheumatol 2000 Jan­Feb;18(1):81­5.
De Keyser F, Naeyaert JM, Hindryckx P, Elewaut D, Verplancke P, Peene I, Praet M, Veys E. Immunemediated pathology following hepatitis B vaccination.
Two cases of polyarteritis nodosa and one case of pityriasis rosea­like drug eruption. Clin Exp Rheumatol 2000 Jan­Feb;18(1):81­5.
De Kleijn ED, de Groot R, Labadie J, Lafeber AB, van den DG, van Alphen L, van Dijken H, Kuipers B, van Omme GW, Wala M, Juttmann R, Rumke HC.
Immunogenicity and safety of a hexavalent meningococcal outer­membrane­vesicle vaccine in children of 2­3 and 7­8 years of age. Vaccine 2000;1456­66.
de Kleijn ED, de Groot R, Lafeber AB, Labadie J, van Limpt KC, Visser J, Berbers GA, van Alphen L, Rumke HC. Immunogenicity and safety of monovalent
p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations. Vaccine 2000
Dec 8;19(9­10):1141­8
De La Rosa JM, Escobedo M. Tuberculosis and other infectious diseases in the adolescent immigrant. Adolesc Med 2000 Jun;11(2):453­66.
De Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn­van Spaendonck MA. Reemergence of pertussis in the highly vaccinated
population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000 Jul­2000 Aug 31;6(4):348­57.
De Moraes, Jd, Barata, R., Ribeiro, M. C., and de Castro, P. C. [Vaccination coverage in the first year of life in 4 cities of the state of Sao Paulo, Brazil]
Rev.Panam.Salud Publica. 2000, 8 (5): 332­341.
De Oliveira LH, Struchiner CJ. Vaccine­associated paralytic poliomyelitis in Brazil, 1989­1995. Rev Panam Salud Publica 2000 Apr;7(4):219­24.
De Oliveira LH, Struchiner CJ. Vaccine­associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil. Int J Epidemiol
2000 Aug;29(4):757­63.
De Serres G. An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation
of combined acellular pertussis, tetanus, and diphtheria vaccine. Can Commun Dis Rep 2000 May 1;26:1­8.
De Wals P. Does informing patients of the risk of acquiring Guillain­Barre syndrome following influenza vaccination have an effect on their willingness to be
vaccinated? Can Commun Dis Rep 2000 Dec 1;26(23):205­7
Dearman, C.; Lazenby, R. B. Community Partnerships: A Win­Win Situation. Nurse Educ; 25 (6): 287; November, 2000.
Decker MD, Edwards KM. Acellular pertussis vaccines. Pediatr Clin North Am 2000; 47(2):309­335.
Decker, M. D. and Edwards, K. M. Combination vaccines: problems and promise [comment] [editorial] J Pediatr 2000 Sep;137(3):291­5
Del Rey, Calero J. [Current interest of antipneumococcal vaccination] An R.Acad.Nac.Med. (Madr.). 2000, 117 (1): 163­178.
Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000­01 influenza season. Advisory Committee on
Immunization Practices. MMWR Morb Mortal Wkly Rep 2000 Jul 14;49(27):619­22.
Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000­01 influenza season. Advisory Committee on
Immunization Practices. MMWR Morb Mortal Wkly Rep 2000 Jul 14;49(27):619­22.
Delpeyroux F, Guillot S, Szendroi A, Balanant J, Caro V, Cuervo N, Chevaliez S, Dahourou G, Crainic R. Intense campaign for vaccination with the oral polio
vaccine: what are the repercussions on the enterovirus world? Bull Soc Pathol Exot 2000 Jul;93(3):193­7.
Demicheli V, Jefferson T, Rivetti D, Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000;957­1030.
DeStefano F, Chen RT. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association. J.Pediatr. 2000;125­6.
Dickson, D. Tests fail to support claims for origin of AIDS in polio vaccine [news] Nature 2000 Sep 14;407(6801):117
Dietz VJ, Baughman AL, Dini EF, Stevenson JM, Pierce BK, Hersey JC. Vaccination practices, policies, and management factors associated with high
vaccination coverage levels in Georgia public clinics. Georgia Immunization Program Evaluation Team. Arch.Pediatr.Adolesc.Med. 2000;184­9.
Dilraj A, Cutts FT, de Castro JF, Wheeler JG, Brown D, Roth C, Coovadia HM, Bennett JV. Response to different measles vaccine strains given by aerosol
and subcutaneous routes to schoolchildren: a randomised trial. Lancet 2000;798­803.
Dini EF, Linkins RW, Sigafoos J. The impact of computer­generated messages on childhood immunization coverage. Am.J.Prev.Med. 2000;132­9.
Dittmann S, Wharton M, Vitek C, Ciotti M, Galazka A, Guichard S et al. Successful control of epidemic diphtheria in the states of the Former Union of Soviet
Socialist Republics: lessons learned. J Infect Dis 2000; 181 Suppl 1:S10­S22.
D'Lugoff, M. I. and Schalla, K. M. Vaccine Verification Guide: Demystifying Childhood Immunizations for Inpatient and Other Nurses Pediatr.Nurs. 2000, 26
(1): 69­75.
Doganci, L.; Saracli, M. A.; Guney, C. Am J Gastroenterol 2000 Aug;95(8):2137.
Donald PR. Preventing tuberculosis in childhood. Indian J Pediatr 2000 May;67(5):383­5.
Donovan RJ, Jalleh G. Positive versus negative framing of a hypothetical infant immunization: the influence of involvement. Health Educ Behav 2000;
27(1):82­95.
Douglas, R. G. Will a new vaccine be used? J Hum Virol 2000 Mar­Apr;3(2):77­80
Dourado I, Cunha S, Teixeira MG, Farrington CP, Melo A, Lucena R, Barreto ML. Outbreak of aseptic meningitis associated with mass vaccination with a
urabe­containing measles­mumps­rubella vaccine: implications for immunization programs. Am.J.Epidemiol. 2000;524­30.
Dourado I, Cunha S, Teixeira MG, Farrington CP, Melo A, Lucena R, Barreto ML. Outbreak of aseptic meningitis associated with mass vaccination with a
urabe­containing measles­mumps­rubella vaccine: implications for immunization programs. Am J Epidemiol 2000 Mar 1;151(5):524­30.
Dove A. Sanctions programs expand despite failure to increase vaccination [news]. Nat.Med. 2000;119.
Drogari­Apiranthitou M, Fijen CA, Van De BD, Hensen EF, Dankert J, Kuijper EJ. Development of antibodies against tetravalent meningococcal
polysaccharides in revaccinated complement­deficient patients. Clin.Exp.Immunol. 2000;311­6.
D'Souza RM, Campbell­Lloyd S, Isaacs D, Gold M, Burgess M, Turnbull F et al. Adverse events following immunisation associated with the 1998 Australian
Measles Control Campaign. Commun Dis Intell 2000; 24(2):27­33.
Duchini A, Viernes ME, Nyberg LM, Hendry RM, Pockros PJ. Hepatic decompensation in patients with cirrhosis during infection with influenza A.
Arch.Intern.Med. 2000;113­5.
Durbach, N. 'They might as well brand us': working­class resistance to compulsory vaccination in Victorian England Soc.Hist Med. 2000, 13 (1): 45­62.